There were 836 press releases posted in the last 24 hours and 442,356 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Corbus Pharmaceuticals Announces FDA Orphan Drug Designation and Fast Track Status of Resunab(TM) for the Treatment of Cystic Fibrosis

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image